BamSEC and AlphaSense Join Forces
Learn More

Biodesix Inc.

NASDAQ: BDSX    
Share price (12/20/24): $1.57    
Market cap (12/20/24): $228 million

Material Contracts Filter

EX-10.1
from 10-Q 2 pages Second Amendment to the Non-Exclusive License Agreement Bio-Rad Laboratories, Inc. /S/ Steve Kulisch By: Steve Kulisch Its: Vp, Product Management Biodesix, Inc. /S/ Robin Harper Cowie By: Robin Harper Cowie Its: Chief Financial Officer
12/34/56
EX-10.42
from S-1 7 pages Biodesix, Inc. Executive Severance and Change in Control Agreement
12/34/56
EX-10.3
from 8-K 56 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 55 pages Securities Purchase Agreement by and Among Biodesix, Inc., and the Purchasers as Set Forth Herein April 5, 2024
12/34/56
EX-10.1
from 8-K 69 pages Securities Purchase Agreement by and Among Biodesix, Inc., and the Purchasers as Set Forth Herein April 5, 2024
12/34/56
EX-10.34
from 10-K 5 pages Limited Waiver
12/34/56
EX-10.1
from 10-Q 26 pages Subscription Agreement
12/34/56
EX-10.2
from 10-Q 3 pages Amendment to Commercial Lease Agreement
12/34/56
EX-10.1
from 10-Q 6 pages Section 2.1
12/34/56
EX-10
from 10-K 2 pages Amendment Number Two to the Biodesix, Inc. 2021 Senior Management Bonus to Equity Plan
12/34/56
EX-10.3
from 8-K 25 pages Subscription Agreement
12/34/56
EX-10.2
from 10-Q 2 pages Amendment Number One to the Biodesix, Inc. 2021 Senior Management Bonus to Equity Plan
12/34/56
EX-10.1
from 10-Q 5 pages Biodesix, Inc. 2021 Senior Management Bonus to Equity Plan 1
12/34/56
EX-10.8
from 10-Q 13 pages Secured Convertible Promissory Note #1
12/34/56
EX-10.7
from 10-Q 69 pages Securities Purchase Agreement
12/34/56
EX-10.6
from 10-Q 5 pages Amendment No. 3 to Asset Purchase Agreement and Plan of Reorganization
12/34/56
EX-10.2
from 10-Q 4 pages First Amendment to Lease Agreement
12/34/56
EX-10.1
from 10-Q 70 pages Basic Provisions and Certain Definitions
12/34/56
EX-10.2
from 8-K 25 pages Subscription Agreement
12/34/56
EX-10.1
from 8-K 31 pages Subscription Agreement
12/34/56